-
Clinical Trials for Neurodegenerative Diseases
Research that focuses on new treatments for patients with neurodegenerative diseases
Learn More
Clinical Trials
Clinical trials are the primary way to determine if a new form of treatment or prevention is safe and effective.
Clinical Hours
Monday-Friday: 8 AM – 4 PM
Address
45 Resnik Road, Suite 205
Plymouth, MA 02360
Phone
Request Information
If you are interested in receiving information about the clinical trials that are being conducted at our site, please complete the form below and a member of our team will contact you.
Headlands Research Eastern MA Services
EMG
This test measures the electrical activity of the muscles when they are working to contract and when they are at rest. EMG testing is used to diagnose conditions that cause muscle tissue damage or damage to the junctions between the muscles and nerves. We perform these on-site.
Lumbar Punctures
This test is also known as a spinal tap. A needle is inserted into the spinal canal, to collect cerebrospinal fluid (CSF) for diagnostic testing. The main reason for a lumbar puncture is to help diagnose diseases of the central nervous system, including the brain and spine. We perform these lumbar punctures here in the office on-site.
EKG
Venipuncture
We have a small laboratory on-site that collects blood tubes for research studies. We are able to process these specimens and ship them for analysis. Our staff members are IATA certified and our laboratory has a CLIA waiver.
Urinalysis
As part of our research studies, we collect urine specimens for routine analysis.
Meet our Team
Donald S. Marks, MD, Neurologist
For over 30 years, Dr. Marks has focused on the treatment of neurodegenerative diseases, specifically in the areas of Alzheimer's and Parkinson's disease. Dr. Marks has been the Principal Investigator (PI) in over 40 clinical trials with numerous pharmaceutical and imaging companies as well as with the National Institutes of Health (NIH). Dr. Marks is a member of the medical staff at the Beth Israel Lahey Health Hospital (BILH) Plymouth and the Nantucket Cottage Hospital. He is the founding Medical Director for the Division of Neurology at the BILH Plymouth.
Kinan Hreib MD, PhD, MBA
Dr. Hreib obtained his MD, Ph.D. and M.B.A. From Boston University and was trained in medicine and Neurology at Boston University Medical Center and Boston City Hospital. His professional life as a neurologist began at Lahey Clinic in Burlington, MA, where he was the director of Vascular Neurology for over twenty years, after which he became the chief of Neurology at Mount Auburn Hospital in Cambridge, MA before becoming the Chief Medical Officer for Baystate Health North. Dr. Hreib continued to see patients as a neurologist while the chief medical executive and later decided to join Donald Marks clinic on neurodegenerative disease in Plymouth.
Elizabeth (Lizzy) Simpson, PA-C
Elizabeth Simpson has been working in Alzheimer’s disease research as a sub-investigator with Dr. Donald Marks since 2021. She also works clinically in the outpatient neurology setting, primarily seeing patients with Alzheimer’s and Parkinson’s disease. Lizzy received her master's degree in medical science at the Tufts University Physician Assistant Program, and her bachelor's degrees at Providence College.
Morgan Tromblee, PA-C
Morgan Tromblee has been working in Alzheimer’s disease research as a sub-investigator with Dr. Donald Marks since 2022. She also works clinically in the outpatient neurology setting, primarily seeing patients with Alzheimer’s and Parkinson’s disease. She received her master's at the MGH Institute of Health Professions Physician Assistant Program, and her bachelor’s in biology at the University of Vermont.
Unraveling Alzheimer's
This video captures the "amyloid hypothesis", the current main (but not proven correct) hypothesis regarding the molecular basis for Alzheimer's. It is the starting point for most current clinical scientific research. Ongoing research is focused on finding more biological causes for Alzheimer's, hoping to discover an easy and an accurate way to detect Alzheimer's at an even earlier stage.
Interested in learning more about Clinical Trials?
Please complete the form below and one of our staff will contact you shortly.
"*" indicates required fields